CompletedPhase 1

A Study of Crenezumab in Participants With Mild to Moderate Alzheimer Disease

NCT02353598

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

Mayo Clinic Scottsdale

Phoenix, Arizona, United States

+12 additional locations

Save this trial

Mayo Clinic ScottsdalePhoenix, Arizona, United States
UCSF - Memory and Aging CenterSan Francisco, California, United States
Brain Matters Research, Inc.Delray Beach, Florida, United States
Miami Jewish Health SystemsMiami, Florida, United States
Bioclinica OrlandoOrlando, Florida, United States
Bioclinica The VillagesThe Villages, Florida, United States
Indiana University School Of Medicine; Department Of NeurologyIndianapolis, Indiana, United States
Hattiesburg ClinicHattiesburg, Mississippi, United States
Millennium Psychiatric Associates, LLCSt Louis, Missouri, United States
Columbia University Medical CenterNew York, New York, United States
UNiversity of RochesterRochester, New York, United States
Rhode Island Mood & Memory Research InstituteEast Providence, Rhode Island, United States
Roper St. Francis Healthcare; Clinical Biotechnology Research InstituteCharleston, South Carolina, United States